Revvity Launches SuperFlex Prenatal Screening System, Expanding Access to Preeclampsia TestingBusiness Wire • 08/10/26
RVTY Q2 Earnings Beat Estimates on Diagnostics Strength, '26 View UpZacks Investment Research • 08/04/26
Revvity (RVTY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 07/28/26
Revvity Develops High-Throughput T-SPOT.TB Platform for Clinical LabsZacks Investment Research • 07/24/26
Revvity Announces Development of High-Throughput T-SPOT.TB Automated Platform for Clinical LabsBusiness Wire • 07/23/26
Revvity to Launch Signals for Startups for Emerging Biotech CompaniesZacks Investment Research • 07/22/26
Revvity Launches “Signals for Startups” to Help Emerging Biotechs Build Scalable Digital Foundations from Day OneBusiness Wire • 07/20/26
Revvity Releases 2026 Impact Report Advancing Transparency with Initial Scope 3 Emissions DisclosureBusiness Wire • 07/20/26
Revvity Launches Signals AI, a Native Agentic Framework for Accelerating Scientific R&DBusiness Wire • 06/22/26
Revvity, Inc. (RVTY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone AssayZacks Investment Research • 05/14/26
Revvity, Inc. (RVTY) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/13/26
Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing SolutionBusiness Wire • 05/13/26